Table 4

Ki values of 5-HT ligands for inhibition of [3H]GR 125743 binding to WT h5-HT1B, h5-HT1D, and the chimeric receptors D/B2ECL+V and B/D2ECL+V expressed in Cos-7 cells

LigandWT h5-HT1BB/D2ECL+VD/B2ECL+VWT h5-HT1D
L 6942471.92  ± 0.051.20  ± 0.15b 0.46  ± 0.161.08  ± 0.43
Zolmitriptan20.58  ± 4.8139.64  ± 9.321.19  ± 0.440.82  ± 0.21
5-HT46.18  ± 3.6939.00  ± 9.545.22  ± 0.895.65  ± 0.66
Sumatriptan78.79  ± 8.33302  ± 59b 5.26  ± 1.196.05  ± 2.08
GR 1279351.97  ± 0.110.96  ± 0.232.41  ± 0.914.85  ± 1.70
SB 2242896.70  ± 0.4810.66  ± 3.46116  ± 21233  ± 71
Ritanserin133  ± 2522.37  ± 7.61a, d 70.13  ± 23.57a, e 16.85  ± 8.16
Ketanserin2902  ± 422115  ± 25c 364  ± 56c 24.02  ± 5.89

Radioligand binding was performed with 1.0 nm[3H]GR 125743 as described in the text. Results (K i, nm) are expressed as mean ± standard error values from three to six independent experiments, each one performed in duplicate.

    • Statistical analysis was performed using Student’s ttest: ap < 0.05,bp < 0.01, cp < 0.001 versus K i values of their respective WT receptors and d not significantly different compared with the WT h5-HT1D receptor, e not significantly different compared with the WT h5-HT1B receptor.